237 related articles for article (PubMed ID: 21354147)
21. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
Liu CZ; Liu W; Zheng Y; Su JM; Li JJ; Yu L; He XD; Chen SS
Chin Med Sci J; 2012 Jun; 27(2):65-72. PubMed ID: 22770403
[TBL] [Abstract][Full Text] [Related]
22. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
Subbaramaiah K; Yoshimatsu K; Scherl E; Das KM; Glazier KD; Golijanin D; Soslow RA; Tanabe T; Naraba H; Dannenberg AJ
J Biol Chem; 2004 Mar; 279(13):12647-58. PubMed ID: 14722058
[TBL] [Abstract][Full Text] [Related]
23. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
24. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
25. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
27. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis.
Golijanin D; Tan JY; Kazior A; Cohen EG; Russo P; Dalbagni G; Auborn KJ; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2004 Feb; 10(3):1024-31. PubMed ID: 14871981
[TBL] [Abstract][Full Text] [Related]
29. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
[TBL] [Abstract][Full Text] [Related]
30. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
31. β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.
Huang GL; Shen DY; Cai CF; Zhang QY; Ren HY; Chen QX
World J Gastroenterol; 2015 Jan; 21(4):1148-57. PubMed ID: 25632187
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis.
Finetti F; Terzuoli E; Bocci E; Coletta I; Polenzani L; Mangano G; Alisi MA; Cazzolla N; Giachetti A; Ziche M; Donnini S
PLoS One; 2012; 7(7):e40576. PubMed ID: 22815767
[TBL] [Abstract][Full Text] [Related]
33. 15d-PGJ₂ decreases PGE₂ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter.
Liu C; Chen S; Wang X; Chen Y; Tang N
Biochem Pharmacol; 2014 Oct; 91(3):337-47. PubMed ID: 25108236
[TBL] [Abstract][Full Text] [Related]
34. Induction of human microsomal prostaglandin E synthase 1 by activated oncogene RhoA GTPase in A549 human epithelial cancer cells.
Choi HJ; Lee DH; Park SH; Kim J; Do KH; An TJ; Ahn YS; Park CB; Moon Y
Biochem Biophys Res Commun; 2011 Sep; 413(3):448-53. PubMed ID: 21907186
[TBL] [Abstract][Full Text] [Related]
35. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non-small-cell lung cancer.
Wang HW; Hsueh CT; Lin CF; Chou TY; Hsu WH; Wang LS; Wu YC
Ann Surg Oncol; 2006 Sep; 13(9):1224-34. PubMed ID: 16952028
[TBL] [Abstract][Full Text] [Related]
37. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2001 Dec; 7(12):3971-6. PubMed ID: 11751489
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.
Itatsu K; Sasaki M; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Zen Y; Sato H; Ohta T; Nagino M; Nimura Y; Nakanuma Y
Am J Pathol; 2009 Mar; 174(3):829-41. PubMed ID: 19218340
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.
Deng G; Hu C; Zhu L; Huang F; Huang W; Xu H; Nie W
Int J Mol Med; 2014 Sep; 34(3):661-8. PubMed ID: 24968753
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
Han C; Wu T
J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
